Safety and tolerability of alogliptin in patients with type 2 diabetes: pooled analysis of 20 double-blind randomised controlled clinical studies

被引：0
|
作者：
Munsaka, M. S. [1 ]
Smith, N. [1 ]
Lee, D. [1 ]
Wilson, C. [1 ]
机构：
[1] Takeda Dev Ctr Amer, Deerfield, IL USA
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
777
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
    Campbell Howard
    Adele Noe
    Andrej Skerjanec
    Björn Holzhauer
    Margaret Wernsing
    Monica Ligueros-Saylan
    Tom Thuren
    Cardiovascular Diabetology, 13
  • [2] Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
    Howard, Campbell
    Noe, Adele
    Skerjanec, Andrej
    Holzhauer, Bjoern
    Wernsing, Margaret
    Ligueros-Saylan, Monica
    Thuren, Tom
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [3] Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysis of 4457 patients from 21 randomized, double-blind, placebo-controlled clinical trials
    Kanasaki, Keizo
    Qu, Shen
    Yamamoto, Fumiko
    Schepers, Cornelia
    Simoes, Rafael Sani
    Yabe, Daisuke
    Ji, Linong
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (03) : 425 - 434
  • [4] Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies
    Berhan, Asres
    Berhan, Yifru
    BMC ENDOCRINE DISORDERS, 2013, 13
  • [5] Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies
    Asres Berhan
    Yifru Berhan
    BMC Endocrine Disorders, 13
  • [6] Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
    Engel, Samuel S.
    Round, Elizabeth
    Golm, Gregory T.
    Kaufman, Keith D.
    Goldstein, Barry J.
    DIABETES THERAPY, 2013, 4 (01) : 119 - 145
  • [7] Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
    Samuel S. Engel
    Elizabeth Round
    Gregory T. Golm
    Keith D. Kaufman
    Barry J. Goldstein
    Diabetes Therapy, 2013, 4 : 119 - 145
  • [8] Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
    Samuel S. Engel
    Elizabeth Round
    Gregory T. Golm
    Keith D. Kaufman
    Barry J. Goldstein
    Diabetes Therapy, 2013, 4 : 487 - 487
  • [9] Safety and tolerability of sitagliptin in patients with type 2 diabetes: A pooled analysis
    Williams-Herman D.
    Round E.
    Swern A.S.
    Musser B.
    Davies M.J.
    Stein P.P.
    Kaufman K.D.
    Amatruda J.M.
    BMC Endocrine Disorders, 8 (1)
  • [10] Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies
    Lehrke, Michael
    Marx, Nikolaus
    Patel, Sanjay
    Seck, Thomas
    Crowe, Susanne
    Cheng, Karen
    von Eynatten, Maximilian
    Johansen, Odd Erik
    CLINICAL THERAPEUTICS, 2014, 36 (08) : 1130 - 1146
12345